Innogenetics Overview
- Year Founded
-
1985
- Status
-
Acquired/Merged
- Employees
-
466
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$112M
- Investors
-
1
Innogenetics General Information
Description
Operator of a biotechnological company dedicated to improving therapy management and patient health. The company develops and markets diagnostic assays with a focus on molecular diagnostics and multiparameter testing.
Contact Information
Website
www.innogenetics.comCorporate Office
- Technologiepark 6
- 9052 Ghent
- Belgium
Corporate Office
- Technologiepark 6
- 9052 Ghent
- Belgium
Innogenetics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Merger/Acquisition | 24-Sep-2010 | $112M | Completed | Generating Revenue | ||
| 11. PIPE | 20-Oct-2008 | Completed | Generating Revenue | |||
| 10. Merger/Acquisition | 05-Sep-2008 | Completed | Generating Revenue | |||
| 9. PIPE | 01-Mar-2007 | Completed | Generating Revenue | |||
| 8. PIPE | 19-Oct-2005 | Completed | Generating Revenue | |||
| 7. PIPE | 01-Mar-2005 | Completed | Generating Revenue | |||
| 6. PIPE | 10-Dec-2003 | Completed | Generating Revenue | |||
| 5. PIPE | 15-Mar-2001 | Completed | Generating Revenue | |||
| 4. PIPE | 05-Dec-1997 | $35.5M | $83.4M | Completed | Generating Revenue | |
| 3. IPO | 28-Nov-1996 | $47.9M | $47.9M | Completed | Generating Revenue |
Innogenetics Signals
Innogenetics Former Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Alta Berkeley | Venture Capital | Minority | ||
| Bayer | Corporation | Minority | ||
| Bio Analytical Research Corporation | Corporation | Minority | ||
| Biovest (Belgium) | Venture Capital | Minority | ||
| CRI BVBA | Corporation | Minority |
Innogenetics Investments (2)
Innogenetics’s most recent deal was a Later Stage VC with CellTran for . The deal was made on 24-Aug-2007.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CellTran | 24-Aug-2007 | Later Stage VC | Drug Discovery | ||
| Cepheid | 30-Nov-1998 | Early Stage VC | Diagnostic Equipment |
Innogenetics FAQs
-
When was Innogenetics founded?
Innogenetics was founded in 1985.
-
Where is Innogenetics headquartered?
Innogenetics is headquartered in Ghent, Belgium.
-
What is the size of Innogenetics?
Innogenetics has 466 total employees.
-
What industry is Innogenetics in?
Innogenetics’s primary industry is Biotechnology.
-
Is Innogenetics a private or public company?
Innogenetics is a Private company.
-
What is the current valuation of Innogenetics?
The current valuation of Innogenetics is .
-
What is Innogenetics’s current revenue?
The current revenue for Innogenetics is .
-
How much funding has Innogenetics raised over time?
Innogenetics has raised $216M.
-
Who are Innogenetics’s investors?
Alta Berkeley, Bayer, Bio Analytical Research Corporation, Biovest (Belgium), and CRI BVBA are 5 of 9 investors who have invested in Innogenetics.
-
When was Innogenetics acquired?
Innogenetics was acquired on 24-Sep-2010.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process